Non-invasive examination for the determination of the fetal trisomies 21, 18 und 13 such as Klinefelter syndrome, Turner-, Triple X-, XYY syndrome and a 22q11.2 microdeletion (associated with DiGeorge syndrome)
Starting from the ninth week of pregnancy (9+0 weeks since LMP) the PrenaTest® determines trisomies 21, 18 and 13, gonosomal aneuploidies (Turner, triple X, Klinefelter, and XYY syndromes) as well as the 22q11.2 microdeletion (associated with the DiGeorge syndrome) from maternal blood. If desired, the gender of the fetus may also be determined. The PrenaTest® can also be performed in the case of a twin pregnancy, following fertility treatment – as well as egg donation.
With the PrenaTest®, you can fully implement the recommendations of medical associations in Germany, Austria and Switzerland, as it offers the appropriate test panel.